Myrtle Pharmaceutical Private Limited - Company Profile

It is a pharma private limited company based in Delhi, Delhi, India, established in 2018.
2018 Delhi, Delhi, India Active
Last Updated:
Access Report
About Myrtle Pharmaceutical Private Limited

Myrtle Pharmaceutical Private Limited, a active private limited company, was established on 30 September 2018 in Delhi, Delhi, India. Engaging in pharmaceutical retailers & distributors within the pharma sector, it holds CIN: U85320DL2018PTC339853. Registered under ROC Roc Delhi I. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.

Its leadership includes Vijai Kumar Asthana (Director), Ranvijay Singh (Director), Neeraj Shukla (Director). It holds ₹0.90 M open charges and no settled loans. Its latest AGM occurred on 30 November 2021, with the balance sheet filed on 31 March 2021. It is based at House No.605, Block-C, Phase - 2 Holambi Kalan, Delhi, Delhi, 110082.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U85320DL2018PTC339853

  • Registration Number

    339853

  • Incorporation Date

    30 September 2018

  • Authorized Capital

    ₹1.00 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Delhi I

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 7 Year, 6 Months
  • Last Filing with ROC 31 Mar 2021
  • Open Charges ₹ 0.90 M
  • Revenue Growth **** 106.45%
  • Profit Growth **** 122.54%
  • Ebitda **** -9748.39%
  • Net Worth 11.35%
  • Total Assets -30.72%
Company report

Myrtle Pharmaceutical Private Limited

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Myrtle Pharmaceutical Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Myrtle Pharmaceutical Private Limited?
Current Directors
Name Designation Appointment Date Status
Vijai Kumar Asthana Director 30 Sep 2018 Current
Ranvijay Singh Director 30 Sep 2018 Current
Neeraj Shukla Director 30 Sep 2018 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Myrtle Pharmaceutical.

Myrtle Pharmaceutical Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 106.45% increase. The company also saw a substantial improvement in profitability, with a 122.54% increase in profit. The company's net worth Soared by an impressive increase of 11.35%.

Myrtle Pharmaceutical revenue growth over time
Myrtle Pharmaceutical profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 106.45%
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
 -30.72%
*******
*******
*******
*******
Profit or Loss
*******
 122.54%
*******
*******
*******
*******
Net Worth
*******
 11.35%
*******
*******
*******
*******
EBITDA
*******
 -9748.39%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Myrtle Pharmaceutical?

Unlock access to Myrtle Pharmaceutical's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹900,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • Bank Of India : 0.09 Cr
Latest Charge Details
Date Lender Amount Status
14 Jan 2021 Bank Of India ₹0.90 M Open

Explore comprehensive loan charge details -

How Many Employees Work at Myrtle Pharmaceutical?

Unlock and access historical data on people associated with Myrtle Pharmaceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Myrtle Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Myrtle Pharmaceutical's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Myrtle Pharmaceutical
Recent Activity within the Organization
  • Annual General Meeting

    The activity Myrtle Pharmaceutical Private Limited last Annual general meeting of members was held on 30 Nov 2021 as per latest MCA records. was completed.

  • Charges

    The activity A charge with Bank Of India of Rs. 0.90 M registered on 14 Jan 2021 with Charge ID 100410704 was modified on 15 Nov 2021. was completed.

  • Balance Sheet

    Progress on Myrtle Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2021 with Roc Delhi I. was documented.

  • Charges

    A charge with Bank Of India amounted to Rs. 0.90 M with Charge ID 100410704 was registered on 14 Jan 2021. was recorded as a recent event.

  • Director Appointment

    Progress on Vijai Kumar Asthana was appointed as a Director was appointed as a Director on 30 Sep 2018 & has been associated with this company since 7 years 6 months . was documented.

  • Director Appointment

    The activity Ranvijay Singh was appointed as a Director was appointed as a Director on 30 Sep 2018 & has been associated with this company since 7 years 6 months . was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Myrtle Pharmaceutical Private Limited?

The CIN of Myrtle Pharmaceutical Private Limited is U85320DL2018PTC339853.

Where is Myrtle Pharmaceutical Private Limited headquartered?

Myrtle Pharmaceutical Private Limited is headquartered at House No.605, Block-C, Phase - 2 Holambi Kalan, Delhi, Delhi, 110082.

When was Myrtle Pharmaceutical Private Limited incorporated?

Myrtle Pharmaceutical Private Limited was incorporated on 30 September 2018.

Who are the current directors of Myrtle Pharmaceutical Private Limited?

The current directors of Myrtle Pharmaceutical Private Limited are

What is the primary industry of Myrtle Pharmaceutical Private Limited?

The primary industry of Myrtle Pharmaceutical Private Limited is Pharma.

Is Myrtle Pharmaceutical Private Limited a listed company?

Myrtle Pharmaceutical Private Limited is unlisted.

What is the capital structure of Myrtle Pharmaceutical Private Limited?

The authorized capital of Myrtle Pharmaceutical Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available